课题基金 / 基金详情

Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID-19 Infection

Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID-19 Infection
喂养 EPA 和 DHA 可改善与 COVID-19 感染相关的临床症状
批准号：
442971
负责人：
Mazurak Vera C
金额：
$25.08万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-11-01 至 2022-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=442971&lang=en
关键词：
Clinical Symptoms Essential Fatty Acids Immune Cells Inflammation Lung Function N-3 Fatty Acids Oxylipins

项目摘要

项目成果

Mazurak Vera C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to find out if the amount of a certain type of fat in the body, called n-3 fatty acids, is related to the severity of COVID-19 symptoms. Currently, it is known that higher amounts of n-3 fatty acids improve outcomes in some co
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dietary EPA and DHA Enhance Tumor Response and Protect against Muscle Loss and Myosteatosis During Chemotherapy Treatment
  • 批准号：
    403509
  • 项目类别：
    Operating Grants
  • 资助金额：
    $54.34万
  • 财政年份：
    2019
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
Factors that Regulate Eicosapentaenoic Acid and Docosahexaenoic Acid to Improve Cancer-Associated Myosteatosis
  • 批准号：
    322909
  • 项目类别：
    Operating Grants
  • 资助金额：
    $47.88万
  • 财政年份：
    2015
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
Supplementation with Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) to Prevent Sarcopenia and Myosteatosis
  • 批准号：
    239577
  • 项目类别：
    Operating Grants
  • 资助金额：
    $31.96万
  • 财政年份：
    2011
  • 负责人：
    Mazurak Vera C
  • 依托单位：
    University of Alberta
海外基金